PAI-1
Plasminogen activator inhibitor-1 (PAI-1) is the primary inhibitor of tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA), and functionally serves to suppress tissue and plasma fibrinolysis.
PAI-1 is a member of the serpin family of proteins and exists in multiple conformations of which a minor component, the “active” form, exhibits inhibitory effects against tPA and uPA.
PAI-1 is an endogenous inhibitor of urokinase-type plasminogen activator (uPA), and its expression is regulated by a number of intrinsic factors (e.g., cytokines and growth factors) and extrinsic factors (e.g., cellular stress).
PAI-1 seems to play a pivotal role in tumor growth and may represent a potential therapeutic target for bladder cancer.
Targets for PAI-1
Products for PAI-1
- Cat.No. Product Name Information
-
GC79737
(S)-ZK824859 hydrochloride
(S)-ZK824859 hydrochloride is a uPA inhibitor and anticoagulant.
-
GC65281
Aleplasinin
PAZ-417
Aleplasinin is an orally active, potent, BBB-penetrated and selectiveSERPINE1 (PAI-1, Plasminogen activator inhibitor-1) inhibitor.
-
GC61511
Angstrom6
A6 Peptide
Angstrom6 (A6 Peptide) is an 8 amino-acid peptide derived from single-chain urokinase plasminogen activator (scuPA) and interferes with the uPA/uPAR cascade and abrogates downstream effects. Angstrom6 binds to CD44 resulting in the inhibition of migration, invasion, and metastasis of tumor cells, and the modulation of CD44-mediated cell signaling.
-
GC68013
CDE-096
-
GC79732
D-Val-Leu-Lys-AMC TFA
D-Val-Leu-Lys-AMC TFA is a selective fluorogenic peptide substrate of plasmin.
-
GC67781
Diaplasinin
PAI-749
-
GA22381
GGACK (H-Glu-Gly-Arg-chloromethylketone)
GGACK (H-Glu-Gly-Arg-chloromethylketone) is an irreversible serine protease inhibitor. GGACK can inhibit urokinase-type plasminogen activator (uPA) and block the plasminogen activation process.
-
GA21910
Glutaryl-Gly-Arg-AMC
Glutaryl-Gly-Arg-AMC is a fluorescent substrate and a peptide substrate of urokinase plasminogen activator (uPA). The maximum excitation/emission wavelength of the fluorophore AMC is 380nm/460nm.
-
GN10267
Loureirin B
-
GC79758
PAI-1-IN-1
PAI-1-IN-1 is an orally active and specific PAI-1 inhibitor with an IC50 of <6.95 μM.
-
GC44671
PPACK
Pebac, D-Phenylalanyl-prolyl-arginyl Chloromethyl Ketone
PPACK is a potent selective and irreversible thrombin inhibitor that inhibits human alpha thrombin with a Ki value of 0.24 nM.
-
GC70534
PPACK TFA
PPACK TFA is a plasminogen activator (rt-PA) inhibitor.
-
GC12387
Tiplaxtinin(PAI-039)
PAI-039, Tiplasinin
Tiplaxtinin(PAI-039) is an orally bioavailable antagonist of plasminogen activator inhibitor-1 (PAI-1) with IC50 value of 2.7μM.
-
GC19358
TM5275 sodium
TM5275 sodium is a plasminogen activator inhibitor (PAI-1) with an IC50 of 6.95 uM.
-
GC18173
TM5441
TM5441 is an orally bioavailable inhibitor of plasminogen activator inhibitor-1 (PAI-1), has IC50 values between 13.9 and 51.1μM and induces intrinsic apoptosis in several human cancer cell lines.
-
GC38971
Toddalolactone
Toddalolactone, a main component of Toddalia asiatica, inhibits the activity of recombinant human plasminogen activator inhibitor-1 (PAI-1), with an IC50 value of 37.31 μM.
-
GC72878
UCD38B hydrochloride
UCD38B drochloride is a cell permeant, competitive enzymatic uPA inhibitor with an IC50 value of 7 μM.
-
GC31889
ZK824859
ZK824859 is an oral available and selective urokinase plasminogen activator (uPA) inhibitor with IC50s of 79?nM, 1580?nM and 1330?nM for human uPA, tPA, and plasmin, respectively.
-
GC34324
ZK824859 hydrochloride
ZK824859 hydrochloride is an oral available and selective urokinase plasminogen activator (uPA) inhibitor with IC50s of 79?nM, 1580?nM and 1330?nM for human uPA, tPA, and plasmin, respectively.